SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying following a strong earnings report that beat analyst estimates for both revenue and earnings per share, signaling a potential turning point for the stock. The community is actively debating whether this movement represents a sustainable recovery for the solar sector or if it is merely a temporary bounce driven by short covering and speculative trading.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors weigh strong Q3 revenue beats and international growth against continued concerns over management's diversification strategy and potential dilution. The community remains deeply divided, with bulls pointing to the company's evolving global medical cannabis footprint as a long-term catalyst, while vocal skeptics remain focused on historical share price declines and skepticism toward the CEO's leadership.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

XPL is experiencing high volatility as investors debate whether the recent price swings and exchange listings represent a genuine utility-driven recovery or a pump-and-dump scheme. The community remains deeply divided, with some highlighting the project's stablecoin infrastructure and potential for adoption, while others express frustration over significant price declines and lack of transparency.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant selling pressure and heightened volatility as investors weigh disappointing delivery figures against the company's aggressive pivot toward AI, robotics, and the potential SpaceX IPO. The community remains deeply divided, with bears pointing to stagnating core automotive demand and leadership concerns, while bulls continue to focus on the long-term potential of the autonomous technology and energy storage sectors.

Investment Managers Series Trust II - Tradr 2X Long AAOI Daily ETF

The Tradr 2X Long AAOI Daily ETF

Investors are actively trading AAOX, a newly launched 2X leveraged ETF designed to amplify the daily performance of Applied Optoelectronics within the high-growth optical networking and AI sector. The community is focused on technical setups and the potential for increased volatility, while navigating the accessibility of this new leveraged instrument across various brokerage platforms.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for investors due to its advanced post-quantum cryptographic security features, which are gaining recognition following recent industry research. While the community remains divided between long-term bulls betting on its technological utility and bears skeptical of its price trajectory, sentiment is shifting as discussions highlight its potential role in secure blockchain infrastructure.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense speculative activity as investors speculate on potential buyout interest from tech giants like Amazon, Apple, and SpaceX, fueled by reports of emerging strategic partnerships and the broader space sector's push toward direct-to-device connectivity. The community remains deeply divided between those betting on an imminent acquisition at a significant premium and those cautioning that these valuation expectations rely on unverified rumors.

Fidelity Covington Trust - Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF is currently gaining attention from investors evaluating top-tier communication sector holdings for long-term growth. Discussions center on the fund's heavy exposure to major tech and media companies, with active debate among the community regarding the potential influence of artificial intelligence on the broader industry and its impact on performance.

Keurig Dr Pepper, Inc. engages in the manufacture, marketing, distribution, and sales of non-alcoholic beverages. It operates through the following segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes beverage concentrates, syrups, and finished beverages including the brands Dr Pepper, Canada Dry, Mott’s, Snapple, A&W, 7UP, Sunkist soda, Squirt, Hawaiian Punch, Core Hydration, Bai, C4 Energy, Clamato, Evian, Yoo-Hoo, Big Red, and Vita Coco. The U.S. Coffee segment involves single serve brewers, specialty, hot and iced varieties, and ready-to-drink beverages. The International segment includes sales in Canada, Mexico, and other markets. The company was founded in 2018 and is headquartered in Frisco, TX.

Keurig Dr Pepper Inc

Keurig Dr Pepper is drawing significant attention as investors react to the company's major acquisition of JDE Peet's and the subsequent plan to split into two independent entities. The community is actively debating the merits of the complex restructuring and the associated debt load, with some analysts noting the significant share price volatility and divergent outlooks on the stock's future value.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing significant upward momentum and high trading volume driven by multiple large orders for its 800G data center transceivers from a major hyperscale customer. The stock is currently a primary focus for traders, with community discussions heavily centered on potential short squeezes, its role in the AI infrastructure supercycle, and the aggressive positioning of institutional players like Jane Street.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

India-EU trade deal: OneSource Specialty, Syngene, Sigachi, other pharma stocks tank up to 19%; here's why

… lower input costs for Indian pharma companies sourcing specialised ingredients from … stocks. On BSE, OneSource Specialty Pharma (19%), Syngene International (11%), Sigachi … .41%), Wanbury Ltd (7%), Kwality Pharmaceuticals (5.67%), Supriya Lifescience (6% …

GSK Pharma to Procure 4.95 MWp Solar Power from CleanMax in Maharashtra

GlaxoSmithKline Pharmaceuticals (GSK Pharma ) will procure 4.95 MWp … , Syngene International, a Bengaluru-based pharmaceutical company, announced procuring renewable energy … February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy …

Healthcare stocks in India fell on Friday as investors weighed the impact of U.S. President Donald Trump’s move to impose a 100% tariff on branded and patented drugs starting Oct. 1.&nbsp;The measure, announced in late-night Truth Social posts, exempts only those manufacturers with U.S. plants that are already under construction or have broken ground.The Nifty Healthcare index fell 1.2% on Thursday, with 18 of its 20 components trading lower.&nbsp;IPCA Laboratories remained unchanged, while Torrent Pharma rose 0.01%.Analyst ViewSEBI-registered analyst&nbsp;<a href="https://stocktwits.com/ra_vishaltrehan">Vishal Trehan</a> said Gland Pharma is the most exposed, given its lack of a U.S. manufacturing footprint and reliance on branded or patented formulations.&nbsp;<stembedurl>https://stocktwits.com/ra_vishaltrehan/message/630078378</stembedurl>He noted that Syngene International, Piramal Pharma, and Zydus Lifesciences stand to benefit from their contract manufacturing models and biologics portfolios, which are less tariff-sensitive.Trehan also pointed out that companies with a large branded generics or biosimilars presence, such as Dr. Reddy’s Laboratories and Biocon, will need to accelerate U.S. production to avoid margin erosion.Trump’s Pharma TariffsThe announcement builds on Trump’s escalating trade measures aimed at repatriating drug manufacturing. Last month, he outlined a phased plan, beginning with a “small tariff” on imported drugs, before lifting duties to 150% within 18 months and ultimately to 250%.&nbsp;Pharmaceuticals had earlier been excluded from his reciprocal tariff program, but the new rules extend to prescription medicines, biologics, specialty drugs, and over-the-counter products, with generic drugs remaining exempt.What Is The Retail Mood?On Stocktwits, retail sentiment for Piramal Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories was ‘bearish’ amid ‘normal’ message volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/GLAND.NSE">Gland Pharma</a> has risen 6.5%, while&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International</a> is down 29.1%,&nbsp;<a href="https://stocktwits.com/symbol/PPLPHARMA.NSE">Piramal Pharma</a> has slipped 25.9%,&nbsp;<a href="https://stocktwits.com/symbol/ZYDUSLIFE.NSE">Zydus Lifesciences</a> is up 1.8%,&nbsp;<a href="https://stocktwits.com/symbol/DRREDDY.NSE">Dr. Reddy’s Laboratories</a> is down 7.2%, and&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a> has fallen 6.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

Equity

Indian equity markets ended higher on Wednesday, supported by strong buying in IT and FMCG stocks. This marked a fifth successive session of gains with the Nifty index ending above 25,000 for the first time since July.The markets are likely to open flat-to-slightly positive on Thursday, tracking broader Asian markets. Investors will be keeping a close watch on the developments around trade talks between India and Russia, as well as the upcoming Shanghai Cooperation Organisation (SCO) summit.The Gift Nifty, an early indicator for the Nifty 50 index, was up 0.11% to 25,113.5 at 8:35 am IST.Here are the stocks to watch out for heading into today’s session.Stocks To WatchVedanta: Board meeting today to mull second interim dividend for this financial year.Clean Science and Technology: Promoters Ashok Boob and Krishna Boob plan to sell up to 24% stake via block deals worth ₹2,626 crore, with a floor price of ₹1,030 per share, as per reports.India Cements: UltraTech Cement will offload a 6.49% stake (2.01 crore shares) through an OFS on August 21–22, with a floor price set at ₹368 per share.RailTel Corporation of India: Bags orders worth ₹50.4 crore, including ₹35 crore from Kerala IT Mission for the SDC project and ₹15.4 crore from Odisha’s Higher Education Department.Jupiter Wagons: Subsidiary Jupiter Tatravagonka Railwheel Factory received an LOI to supply 5,376 wheelsets for Vande Bharat Trains, valued at ₹215 crore.Zee Entertainment: Aditya Birla Finance challenges an arbitral award in the Delhi High Court. The dispute pertains to a ₹134-crore term loan to Siti Networks, linked to a letter of comfort allegedly issued by Zee.Exide Industries: Invests ₹100 crore in its subsidiary Exide Energy Solutions via rights issue, taking its total investment to ₹3,802.23 crore without altering its shareholding.Godrej Properties: Acquires a 7% stake in Godrej Skyline Developers from an existing shareholder.Syngene International: Appoints five senior leaders across strategy, technology, research, chemistry, and biology, all joining its Executive Committee.Sula Vineyard: Reportedly exploring entry into premium spirits and is in talks with smaller brands for potential acquisitions to foray into whisky, scotch, and vodka markets.Fortis Healthcare: Signs an agreement with Ekana Group to manage a 550-bed super specialty hospital in Lucknow’s Gomti Nagar.Hitachi Energy India: Board appoints Ismo Antero Haka as Chairman and Jan Niklas Persson as Additional Director, while Achim Michael Braun stepped down.Innova Captab: Clears UK-MHRA inspection for its Cephalosporin plant in Baddi with no major or critical observations.Nucleus Software Exports: Vishnu R Dusad named Interim CFO effective August 20, while continuing as Managing Director.SMC Global Securities: To invest ₹15 crore in equity shares of NCDEX.Popular Vehicles and Services: Subsidiary Prabal Motors acquires BharatBenz dealership operations in Punjab from Globe CV.Paradeep Parivahan: Acquires 100% stake in four entities: Pharmachem Traders, Nirkon Industries, MRTC (India), and ASK Logistiek Solutio.Crisil: Subsidiary Crisil Irevna UK approves setting up a wholly owned arm, Crisil Canada Inc.Thermax: Acquires the remaining 23.03% stake in Thermax Bioenergy Solutions, making it a wholly owned subsidiary.Fedbank Financial Services: Board to meet on August 25 to consider issuing NCDs worth up to ₹2,500 crore.Signpost India: Partners with EY LLP for a three-year transformation program focused on governance, digital infrastructure, and scalability.CAMS: RBI clears transfer of CAMS’ payment aggregator business to its subsidiary CAMSPAY, after which CAMS will surrender its license.Enviro Infra Engineers: PTC India Financial Services signed agreements with subsidiary EIE Renewables for management transfer of Vento Power Infra under a ₹115.6 crore debt resolution plan.Poly Medicure: NCLT Allahabad has approved the company’s resolution plan for Himalayan Mineral Waters under IBC.Super Iron Foundry: Subsidiary SIF Saudi Arabia signs a 10-year land lease with Saudi Industrial Authority to set up a new foundry unit.Prostarm Info Systems: Emerges as L-1 bidder for a 150 MW / 300 MWh battery energy storage system at Gadag, Karnataka, for KPTCL.RACL Geartech: Secures long-term order to supply transmission gears for premium motorcycles from a leading Indian manufacturer.Earnings ImpactShanti Gold International:&nbsp;Q1 Profit zooms 174% to ₹24.6 crore, while revenue increases 22.1% to ₹292.8 croreActive IPOsGem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, Mangal Electrical IndustriesFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For August 21: Vedanta, Zee Entertainment, Clean Science, India Cements, Railtel Are On Stocks Watchlist

Gem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, and Mangal Electrical Industries IPOs are currently open for subscription

Syngene International reports 11% revenue growth and 59% net profit surge in Q1

Syngene International, a Biocon subsidiary, reveals an 11% revenue increase to Rs 875 crore for the first quarter. Net profit jumps 59% to Rs 87 crore. Growth is attributed to research services and biologics manufacturing. Operations commenced at Unit III in Bengaluru. Preparations advance for the Bayview facility in the US.

Ahead of reporting its quarterly results on Wednesday, Syngene International, a pharmaceutical sector services provider, appears to be locked in a range-bound trade.The stock is currently positioned just above a key support zone between ₹645 and ₹669, as observed by SEBI-registered <a href="https://stocktwits.com/billiondreamz">analyst Rohit Mehta</a>. A recent bounce from this level, accompanied by rising volume, suggests the emergence of short-term bullish momentum.<stembedurl>https://stocktwits.com/billiondreamz/message/621887004</stembedurl>While the broader trend remains corrective since its December 2024 peak, the current consolidation near support could signal the early stages of a base formation. A sustained move above ₹700 would confirm strength, while ₹960 remains a key resistance on the upside, Mehta said.Currently trading at ₹683, <a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International shares</a> are down 29% from its all-time high of ₹960.20.From an operating standpoint, the company reported healthy results in the March 2025 quarter. Revenue rose 11.01%, while operating profit grew 8.52%, although EPS slipped 3%. Despite solid operating metrics, valuation remains on the higher side at 5.78 times book value, with a modest 12.3% ROE and a low dividend payout of 10.3%.Promoter holding dipped slightly to 52.68% in June 2025, while foreign institutional investors (FIIs) reduced their stake from 19.47% to 16.51%. Domestic institutional investors (DIIs), however, increased their holding to 24.05%.Syngene has witnessed a heavy selling pressure this year, with the stock losing over a fifth of its value YTD.However, it currently appears to be stabilizing near a strong support zone with investors cautiously awaiting the results, hopeful of a trend reversal.For updates and corrections, email newsroom[at]stocktwits[dot]com

A man browses a stock market app during the union budget announcement by Nirmala Sitharaman at the Bombay Stock Exchange headquarters in Mumbai, India, on February 1, 2025. (Photo by Indranil Aditya/NurPhoto via Getty Images)

Syngene Consolidates Ahead Of Q1 Earnings: SEBI RA Rohit Mehta Sees Potential Breakout Above ₹700

Ahead of reporting its quarterly results on Wednesday, Syngene International, a pharmaceutical sector services provider, appears to be locked in a range-bound trade.

While past earnings have been positive, the stock trades at a high valuation and offers a low dividend payout

India’s renewable energy, pharmaceutical, and infrastructure sectors are gaining investor attention heading into July, driven by structural growth drivers such as government incentives, global demand, and a stable policy environment.SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/billiondreamz">Rohit Mehta</a> said smart money is rotating into these three sectors, driven by long-term fundamentals.&nbsp;<stembedurl>https://stocktwits.com/billiondreamz/message/619543180</stembedurl>In renewable energy, Mehta cited India’s ₹24,000 crore PLI scheme for solar modules, rising domestic installations toward the 175+ GW 2030 target, and global deals like Waaree Solar Americas’ 540 MW order.&nbsp;He flagged&nbsp;<a href="https://stocktwits.com/symbol/WAAREEENER.NSE">Waaree Energies</a>,&nbsp;<a href="https://stocktwits.com/symbol/INOXWIND.NSE">Inox Wind</a>,&nbsp;<a href="https://stocktwits.com/symbol/SERVOTECH.NSE">Servotech Power</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KPIGREEN.NSE">KPI Green Energy</a> as key stocks to watch.In pharma, Mehta noted a shift from low-margin generics to high-value contract research and manufacturing services (CRAMS), contract development and manufacturing organizations (CDMO), and biosimilars, driven by the China+1 strategy and increased production-linked incentive (PLI) support.&nbsp;<a href="https://stocktwits.com/symbol/SUVEN.NSE">Suven Pharma</a>,&nbsp;<a href="https://stocktwits.com/symbol/DIVISLAB.NSE">Divi’s Labs</a>,&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a>,&nbsp;<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE">Neuland Labs</a>, and&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene</a> were highlighted for their strong positioning.On infrastructure, Mehta pointed to ₹11 lakh crore in capital expenditure plans in the FY26 Budget and continued momentum in railways, metros, defense, and electrification.&nbsp;He named&nbsp;<a href="https://stocktwits.com/symbol/LTTS.NSE">L&amp;T</a>,&nbsp;<a href="https://stocktwits.com/symbol/IRB.NSE">IRB Infra</a>,&nbsp;<a href="https://stocktwits.com/symbol/KEC.NSE">KEC International</a>,&nbsp;<a href="https://stocktwits.com/symbol/KNRCON.NSE">KNR Construction</a>,&nbsp;<a href="https://stocktwits.com/symbol/AHLUCONT.NSE">Ahluwalia Contracts</a>,&nbsp;<a href="https://stocktwits.com/symbol/POLYCAB.NSE">Polycab</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KEI.NSE">KEI Industries</a> as top beneficiaries.For updates and corrections, email newsroom[at]stocktwits[dot]com.

July Stock Themes: SEBI RA Rohit Mehta Flags Renewables, Pharma, Infra Sectors For Big Rotations

India's clean energy push, pharma transformation, and record capex plans are drawing investor focus heading into July, with key beneficiaries emerging across all three sectors. 

Syngene International Ltd. engages in the contract research and manufacturing services to pharmaceutical and biotechnology companies. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.

SYNGENE.NSE
Syngene International Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SYNGENE.NSE News

SYNGENE.NSESyngene International Ltd.